Nefdapa 10 Tablet
By Nefdapa
Rx
15 Tablet in a Strip

Composition
Dapagliflozin(10mg)

Manufacturer - Hospimax Healthcare Pvt Ltd
109, First Floor, DDA Building No. 5 District Centre, Janakpuri New Delhi West Delhi DL 110058 IN

Expires on or after
September, 2025

liver
Nefdapa 10 Tablet is considered safe for use in individuals with liver disease. It is important to note that no specific changes in the dosage of Nefdapa 10 Tablet are necessary for patients with liver conditions. This means that individuals with liver issues can generally take Nefdapa 10 Tablet without the need for dosage adjustments. It is still advisable to consult with a healthcare provider for personalized guidance before starting or continuing the use of Nefdapa 10 Tablet in case of any concerns related to liver health.

kidney
Nefdapa 10 Tablet should be avoided by patients with kidney disease as it may be unsafe. Consult your doctor before using.

alcohol
It is unsafe to drink alcohol while taking Nefdapa 10 Tablet. Caution should be taken during pregnancy.

driving
When your blood sugar levels are too low or too high, it can affect your driving ability. If you experience symptoms, avoid driving.

pregnancy
Nefdapa 10 Tablet may not be safe to use during pregnancy as animal studies suggest harmful effects on the baby. Your doctor will consider benefits and risks before prescribing. Please consult your doctor before use.

breastfeeding
Caution is advised when using Nefdapa 10 Tablet while breastfeeding. Limited data indicates potential harm to the baby as the drug might pass into breastmilk.
Habit Forming | No |
Chemical Class | Phenolic Glycosides Derivative |
Therapeutic Class | ANTI DIABETIC |
Action Class | SGLT2 inhibitors |
₹110
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024